MNBTD
PTLA

Moody National Bank Trust Division’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Moody National Bank Trust Division’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-399
Closed -$14K – 1124
2019
Q1 		$14K Buy
+399
New +$11.5K ﹤0.01% 606

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

Moody National Bank Trust Division's PTLA Position: Q2 2019 in Review

Moody National Bank Trust Division sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2019, closing a stake of 399 shares — an estimated $14K sold.

Moody National Bank Trust Division first reported a position in PTLA in Q1 2019 and held it in 1 quarter. The position peaked at $14K in Q1 2019. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

  • Moody National Bank Trust Division reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Moody National Bank Trust Division sold 399 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $14K.
  • Moody National Bank Trust Division first reported a position in Portola Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
  • Moody National Bank Trust Division's Portola Pharmaceuticals, Inc. position peaked at $14K in Q1 2019.
  • 202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on Moody National Bank Trust Division's 13F filing for Q2 2019, filed 22 Jul 2019.